|
1
|
Genomic alterations in cultured human embryonic stem cells.
|
Nat Genet
|
2005
|
3.89
|
|
2
|
Human embryonic stem cells have a unique epigenetic signature.
|
Genome Res
|
2006
|
2.89
|
|
3
|
Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes.
|
Stem Cell Res
|
2010
|
1.51
|
|
4
|
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.
|
J Mol Cell Cardiol
|
2012
|
1.20
|
|
5
|
Differentiating human embryonic stem cells express a unique housekeeping gene signature.
|
Stem Cells
|
2007
|
1.18
|
|
6
|
Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells.
|
Stem Cells
|
2008
|
1.16
|
|
7
|
Monitoring differentiation of human embryonic stem cells using real-time PCR.
|
Stem Cells
|
2005
|
1.11
|
|
8
|
Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.
|
Stem Cell Rev
|
2010
|
1.09
|
|
9
|
Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue.
|
Physiol Genomics
|
2011
|
0.95
|
|
10
|
Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.
|
J Appl Toxicol
|
2011
|
0.95
|
|
11
|
Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes.
|
Exp Biol Med (Maywood)
|
2006
|
0.93
|
|
12
|
Human embryonic stem cells: current technologies and emerging industrial applications.
|
Crit Rev Oncol Hematol
|
2007
|
0.93
|
|
13
|
Clonal derivation and characterization of human embryonic stem cell lines.
|
J Biotechnol
|
2005
|
0.89
|
|
14
|
Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes.
|
Expert Opin Drug Discov
|
2009
|
0.85
|
|
15
|
Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.
|
J Biotechnol
|
2010
|
0.84
|
|
16
|
Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue.
|
Physiol Genomics
|
2010
|
0.83
|
|
17
|
New cell models and assays in cardiac safety profiling.
|
Expert Opin Drug Metab Toxicol
|
2007
|
0.83
|
|
18
|
Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage.
|
Stem Cells Dev
|
2010
|
0.82
|
|
19
|
Cardiomyocyte clusters derived from human embryonic stem cells share similarities with human heart tissue.
|
J Mol Cell Biol
|
2010
|
0.82
|
|
20
|
Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
|
Curr Opin Drug Discov Devel
|
2009
|
0.80
|
|
21
|
High-resolution analysis of the subtelomeric regions of human embryonic stem cells.
|
Stem Cells
|
2005
|
0.80
|
|
22
|
Cardiomyogenic gene expression profiling of differentiating human embryonic stem cells.
|
J Biotechnol
|
2007
|
0.78
|
|
23
|
A novel 3D label-free monitoring system of hES-derived cardiomyocyte clusters: a step forward to in vitro cardiotoxicity testing.
|
PLoS One
|
2013
|
0.77
|
|
24
|
Can stem-cell-derived models revolutionize drug discovery?
|
Expert Opin Drug Discov
|
2013
|
0.75
|